Post Cardiac Surgery Staph Vaccine Study

Apr 4, 2011Clinical Trial, Vaccines

Post surgical infection is potentially dangerous for recovering heart patients, This study tests the effectiveness of a vaccine to prevent Staphylococcus aureus infection in patients 18 and older.

Staph Vaccine Basic qualifications are:

  • 18 years and older
  • Male or Female
  • Patient must be scheduled to undergo cardiothoracic surgery involving a full median sternotomy
  • Ability to complete study

If you qualify you may receive:

  • Study related exam
  • Investigational vaccine
  • Compensation up to $300 for time and travel related to the study

Visit the enrollment page on our website to sign up to see if you qualify.

jbrclinicalresearch.com